• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎消除后门静脉高压患者行肝大部切除术的围手术期安全管理:一例报告

Safe perioperative management of major hepatectomy in a patient with portal hypertension after elimination of hepatitis C: a case report.

作者信息

Hamura Ryoga, Onda Shinji, Shirai Yoshihiro, Yasuda Jungo, Haruki Koichiro, Furukawa Kenei, Sakamoto Taro, Gocho Takeshi, Ikegami Toru

机构信息

Division of Hepatobiliary and Pancreas Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.

出版信息

Surg Case Rep. 2022 Jan 4;8(1):3. doi: 10.1186/s40792-021-01357-7.

DOI:10.1186/s40792-021-01357-7
PMID:34982291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8727663/
Abstract

BACKGROUND

The administration of direct-acting antiviral agents in patients with liver cirrhosis and hepatitis C has been shown to improve liver function and long-term prognosis after sustained virological response (SVR) is achieved. However, in patients with portal hypertension (PH) at the time of SVR, PH may persist despite improvement in liver function.

CASE PRESENTATION

An 82-year-old woman with liver cirrhosis due to hepatitis C was treated with direct-acting antiviral agents and achieved SVR. During follow-up, computed tomography revealed a low-density tumor in the left lateral region of the liver with dilation of the left intrahepatic bile duct. Considering the patient's advanced age and PH persistence with a mild decrease in liver reserve function after SVR, preoperative percutaneous transhepatic portal embolization (PTPE) and partial splenic embolization (PSE) were performed concomitantly. Laparoscopic left hemihepatectomy was performed 8 days after the PTPE and PSE. The patient was discharged 8 days after surgery without any postoperative complications.

CONCLUSIONS

Laparoscopic left hemihepatectomy after preoperative management of PH was performed safely in a patient after the elimination of hepatitis C.

摘要

背景

在肝硬化合并丙型肝炎患者中应用直接抗病毒药物已显示,在实现持续病毒学应答(SVR)后可改善肝功能和长期预后。然而,在SVR时存在门静脉高压(PH)的患者中,尽管肝功能有所改善,但PH可能仍然持续存在。

病例报告

一名82岁因丙型肝炎导致肝硬化的女性接受了直接抗病毒药物治疗并实现了SVR。在随访期间,计算机断层扫描显示肝左外侧区域有一个低密度肿瘤,左肝内胆管扩张。考虑到患者年龄较大且SVR后PH持续存在,肝脏储备功能轻度下降,术前同时进行了经皮经肝门静脉栓塞术(PTPE)和部分脾栓塞术(PSE)。在PTPE和PSE术后8天进行了腹腔镜左半肝切除术。患者术后8天出院,无任何术后并发症。

结论

在一名丙型肝炎清除后的患者中,术前对PH进行处理后安全地实施了腹腔镜左半肝切除术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7194/8727663/c1d753af98ca/40792_2021_1357_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7194/8727663/4612d5932aa9/40792_2021_1357_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7194/8727663/9f698a4544b8/40792_2021_1357_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7194/8727663/c1d753af98ca/40792_2021_1357_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7194/8727663/4612d5932aa9/40792_2021_1357_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7194/8727663/9f698a4544b8/40792_2021_1357_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7194/8727663/c1d753af98ca/40792_2021_1357_Fig3_HTML.jpg

相似文献

1
Safe perioperative management of major hepatectomy in a patient with portal hypertension after elimination of hepatitis C: a case report.丙型肝炎消除后门静脉高压患者行肝大部切除术的围手术期安全管理:一例报告
Surg Case Rep. 2022 Jan 4;8(1):3. doi: 10.1186/s40792-021-01357-7.
2
Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation.经皮经肝门静脉栓塞术与单侧门静脉结扎术的比较。
World J Gastroenterol. 2012 May 21;18(19):2371-6. doi: 10.3748/wjg.v18.i19.2371.
3
Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report.腹腔镜胆囊切除术中严重胆管损伤采用经皮经肝胆管引流和门静脉栓塞的根治性手术逐步治疗方法:病例报告
Surg Case Rep. 2016 Dec;2(1):27. doi: 10.1186/s40792-016-0154-5. Epub 2016 Mar 17.
4
Repeat hepatectomy for colonic liver metastasis presenting intrabiliary growth--application of percutaneous transhepatic portal vein embolization for impaired liver.针对出现肝内胆管生长的结肠肝转移灶行再次肝切除术——经皮经肝门静脉栓塞术在肝功能受损中的应用
Hepatogastroenterology. 2007 Jul-Aug;54(77):1554-6.
5
Percutaneous transhepatic portal embolization using foam ethanolamine oleate and carbon dioxide (CO₂): a pilot study.使用油酸乙醇胺泡沫和二氧化碳(CO₂)进行经皮经肝门静脉栓塞术:一项初步研究。
Acta Radiol. 2015 Nov;56(11):1361-7. doi: 10.1177/0284185115590285. Epub 2015 Jun 24.
6
[Percutaneous transhepatic portal vein embolization for hepatocellular carcinoma].经皮肝门静脉栓塞治疗肝细胞癌
Nihon Geka Gakkai Zasshi. 1998 Apr;99(4):234-40.
7
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.临床显著门静脉高压患者经口服抗病毒治疗根除丙型肝炎病毒后的临床结局和血流动力学变化。
J Hepatol. 2020 Dec;73(6):1415-1424. doi: 10.1016/j.jhep.2020.05.050. Epub 2020 Jun 12.
8
Course before and after percutaneous transhepatic portal vein embolization of a patient with cholangiocarcinoma monitored by scintigraphy with Tc-99m galactosyl human serum albumin.通过用Tc-99m半乳糖基人血清白蛋白闪烁显像监测的胆管癌患者经皮经肝门静脉栓塞前后的病程
Ann Nucl Med. 2000 Jun;14(3):231-4. doi: 10.1007/BF02987867.
9
Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case Report.使用介入放射学(IVR)治疗丙型肝炎病毒(HCV)相关失代偿期肝硬化的新型治疗策略:病例报告
Am J Case Rep. 2019 Nov 18;20:1699-1704. doi: 10.12659/AJCR.919240.
10
Successful treatment of isolated bile leakage after hepatectomy combination therapy with percutaneous transhepatic portal embolization and bile duct ablation with ethanol: a case report.经皮经肝门静脉栓塞联合乙醇胆管消融治疗肝切除术后孤立性胆漏的成功案例报道
Surg Case Rep. 2018 Jun 19;4(1):61. doi: 10.1186/s40792-018-0463-y.

本文引用的文献

1
Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis.肝硬化患者脾切除或脾动脉栓塞术后发生肠系膜静脉血栓形成:系统评价和荟萃分析。
Adv Ther. 2021 Apr;38(4):1904-1930. doi: 10.1007/s12325-021-01652-7. Epub 2021 Mar 9.
2
Multimodal approach to portal hypertension and gastric varices before hepatic resection for hepatocellular carcinoma: a case report.肝细胞癌肝切除术前门静脉高压症和胃静脉曲张的多模式治疗方法:一例报告
Surg Case Rep. 2020 Jul 31;6(1):190. doi: 10.1186/s40792-020-00952-4.
3
Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.
腹腔镜肝切除术:肝硬化和门静脉高压患者的优势是什么?系统评价和荟萃分析及个人经验。
J Laparoendosc Adv Surg Tech A. 2020 Oct;30(10):1054-1065. doi: 10.1089/lap.2020.0408. Epub 2020 Jul 20.
4
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy.肝静脉压力梯度变化可预测获得无干扰素治疗持续病毒学应答患者的肝失代偿。
Hepatology. 2020 Mar;71(3):1023-1036. doi: 10.1002/hep.30885. Epub 2019 Oct 14.
5
Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.肝癌患者行肝切除术后的门静脉高压症围手术期处理。
Br J Surg. 2019 Jul;106(8):1066-1074. doi: 10.1002/bjs.11153. Epub 2019 Apr 16.
6
Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.在伴有或不伴有利巴韦林的情况下,索磷布韦-维帕他韦治疗失代偿期肝硬化的 HCV 感染日本患者的疗效和安全性:一项开放标签 3 期试验。
J Gastroenterol. 2019 Jan;54(1):87-95. doi: 10.1007/s00535-018-1503-x. Epub 2018 Sep 10.
7
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.口服抗病毒治疗对丙型肝炎病毒相关性肝硬化患者肝静脉压力梯度和全身血液动力学的影响。
Gastroenterology. 2017 Nov;153(5):1273-1283.e1. doi: 10.1053/j.gastro.2017.07.016. Epub 2017 Jul 20.
8
A portal pressure cut-off of 15 versus a cut-off of 20 for prevention of small-for-size syndrome in liver transplantation: A comparative study.肝移植中预防小肝综合征的门静脉压力截断值15与截断值20的比较研究。
Hepatol Res. 2017 Mar;47(4):293-302. doi: 10.1111/hepr.12727. Epub 2016 May 11.
9
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies.无干扰素抗病毒疗法改善晚期丙型肝炎病毒相关性肝硬化患者的肝功能参数
Aliment Pharmacol Ther. 2015 Oct;42(7):889-901. doi: 10.1111/apt.13343. Epub 2015 Aug 6.
10
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.来迪派韦索磷布韦与利巴韦林联合治疗晚期肝病患者的 HCV 感染。
Gastroenterology. 2015 Sep;149(3):649-59. doi: 10.1053/j.gastro.2015.05.010. Epub 2015 May 15.